메뉴 건너뛰기




Volumn 7, Issue 9, 2015, Pages 407-410

Acute liver failure after initiation of rivaroxaban: A case report and review of the literature

Author keywords

Drug toxicity; Liver failure; Rivaroxaban

Indexed keywords

RIVAROXABAN;

EID: 84943183384     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.166221     Document Type: Article
Times cited : (16)

References (16)
  • 2
    • 84882909945 scopus 로고    scopus 로고
    • Novel oral anticoagulants: Clinical pharmacology, indications and practical considerations
    • Harder S, Graff J. Novel oral anticoagulants: Clinical pharmacology, indications and practical considerations. Eur J Clin Pharmacol 2013;69:1617-33.
    • (2013) Eur J Clin Pharmacol , vol.69 , pp. 1617-1633
    • Harder, S.1    Graff, J.2
  • 3
    • 84879529997 scopus 로고    scopus 로고
    • Importance of pharmacokinetic profi le and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban
    • Gong IY, Kim RB. Importance of pharmacokinetic profi le and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban. Can J Cardiol 2013;29(Suppl):S24-33.
    • (2013) Can J Cardiol , vol.29
    • Gong, I.Y.1    Kim, R.B.2
  • 5
    • 79951784125 scopus 로고    scopus 로고
    • Evaluation of drug-induced serious hepatotoxicity (EDISH): Application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery
    • Watkins PB, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, et al. Evaluation of drug-induced serious hepatotoxicity (eDISH): Application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 2011;34:243-52.
    • (2011) Drug Saf , vol.34 , pp. 243-252
    • Watkins, P.B.1    Desai, M.2    Berkowitz, S.D.3    Peters, G.4    Horsmans, Y.5    Larrey, D.6
  • 6
    • 84907964271 scopus 로고    scopus 로고
    • Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban
    • Liakoni E, Rätz Bravo A, Terracciano L, Heim M, Krähenbühl S. Symptomatic hepatocellular liver injury with hyperbilirubinemia in two patients treated with rivaroxaban. JAMA Intern Med 2014;174:1683-6.
    • (2014) JAMA Intern Med , vol.174 , pp. 1683-1686
    • Liakoni, E.1    Rätz Bravo, A.2    Terracciano, L.3    Heim, M.4    Krähenbühl, S.5
  • 9
    • 0027362542 scopus 로고
    • Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
    • Danan G, Benichou C. Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1323-1330
    • Danan, G.1    Benichou, C.2
  • 10
    • 84893649169 scopus 로고    scopus 로고
    • Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment
    • Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014;6:17-32.
    • (2014) World J Hepatol , vol.6 , pp. 17-32
    • Teschke, R.1    Wolff, A.2    Frenzel, C.3    Schwarzenboeck, A.4    Schulze, J.5    Eickhoff, A.6
  • 11
    • 0037126649 scopus 로고    scopus 로고
    • U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
    • Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
    • (2002) Ann Intern Med , vol.137 , pp. 947-954
    • Ostapowicz, G.1    Fontana, R.J.2    Schiødt, F.V.3    Larson, A.4    Davern, T.J.5    Han, S.H.6
  • 12
    • 77952847965 scopus 로고    scopus 로고
    • Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: Unifi ed list based on international collaborative work
    • Suzuki A, Andrade RJ, Bjornsson E, Lucena MI, Lee WM, Yuen NA, et al. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: Unifi ed list based on international collaborative work. Drug Saf 2010;33:503-22.
    • (2010) Drug Saf , vol.33 , pp. 503-522
    • Suzuki, A.1    Rade, R.J.2    Bjornsson, E.3    Lucena, M.I.4    Lee, W.M.5    Yuen, N.A.6
  • 13
    • 0027448634 scopus 로고
    • Causality assessment of adverse reactions to drugs — II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
    • Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs — II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol 1993;46:1331-6.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1331-1336
    • Benichou, C.1    Danan, G.2    Flahault, A.3
  • 16
    • 84886852658 scopus 로고    scopus 로고
    • Hyperacute drug-induced hepatits with intravenous amiodarone: Case report and review of the literature
    • Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA. Hyperacute drug-induced hepatits with intravenous amiodarone: Case report and review of the literature. Drug Healthc Patient Saf 2015;5:191-8.
    • (2015) Drug Healthc Patient Saf , vol.5 , pp. 191-198
    • Nasser, M.1    Larsen, T.R.2    Waanbah, B.3    Sidiqi, I.4    McCullough, P.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.